Alternate Health Corp. (C:AHG)
Business Focus: Alternative Medicine
| Sector: Healthcare | Industry: Pharmaceuticals |
| Company Contact | |
| Address: | Suite 200, 99 Yorkville Avenue TORONTO ON M5R 3K5 |
| Tel: | N/A |
| Website: | https://alternatehealth.com |
| IR: | See website |
| Key People | ||
| N/A | ||
| Business Overview |
| Alternate Health Corp. is a Canada-based hemp-derived cannabidiol (CBD) company. The Company manufactures, packages, and distributes pharmaceutical grade products across the United States. It is a diverse healthcare provider that uses technology and data analytics for patient care and research in the CBD industry. Through its subsidiaries, it offers services ranging from medical practice and management software, clinical research and continuing education programs. Its products line includes topical creams and tinctures for the treatment of pain, scares, and fungus. It also manufactures and distributes Hempnesic, which is a hemp-based pain management cream. The Company's software systems provide the platform for its diverse operations, including CBD product distribution, hemp-derived extract manufacturing, blockchain tax collection systems, education modules and electronic medical records (EMR) platforms. Its subsidiaries include Alternate Health, Inc. and Alternate Health USA Inc. |
| Financial Overview |
| For the nine months ended 30 September 2019, Alternate Health Corp revenues increased from C$1.2M to C$5.1M. Net loss decreased 56% to C$5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Bad debts decrease from C$3.4M (expense) to C$0K, Salaries and other benefits decrease of 45% to C$2M (expense), Lab Supplies decrease from C$1.2M (expense) to C$0K. |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $0.45M as of Sep 30, 2019 |
| Annual revenue (TTM): | $3.22M as of Sep 30, 2019 |
| EBITDA (TTM): | -$6.14M as of Sep 30, 2019 |
| Net annual income (TTM): | -$12.89M as of Sep 30, 2019 |
| Free cash flow (TTM): | -$4.12M as of Sep 30, 2019 |
| Net Debt Last Fiscal Year: | $0.45M as of Sep 30, 2019 |
| Shares outstanding: | 91,484,212 as of Jun 4, 2020 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
